COVID‐19 and the pulmonary complications of sickle cell disease

Sickle cell disease (SCD) patients are commonly affected by pulmonary complications such as acute chest syndrome (ACS), pulmonary embolism (PE) and pneumonia that contribute to significant mortality risks. With a greater susceptibility to infection, they are deemed to be vulnerable patients during t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivalingam, Thivya, Inusa, Baba, Doyle, Pat, Oteng‐Ntim, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675298/
https://www.ncbi.nlm.nih.gov/pubmed/33230510
http://dx.doi.org/10.1002/jha2.105

Ejemplares similares

Ejemplares similares